Barcelona, Spain

Oscar Huertas Gambín

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Oscar Huertas Gambín

Introduction

Oscar Huertas Gambín is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of biotechnology, particularly in the development of pharmaceutical compositions. With a total of 2 patents to his name, his work focuses on innovative solutions for medical treatments.

Latest Patents

One of his latest patents is centered around sustained release compositions comprising micronized tolcapone. This invention relates to a sustained release tablet that includes micronized tolcapone, a release retardant, and a binder. The tablet is designed for use in the prevention and/or treatment of transthyretin-associated amyloidosis. The patent outlines a method for administering an effective amount of the tablet to a subject in need, as well as a pharmaceutical composition in the form of the tablet. Additionally, it details a process for the manufacture of this tablet, showcasing the practical applications of his invention.

Career Highlights

Oscar is currently associated with Som Innovation Biotech, S.L., where he continues to push the boundaries of biotechnological research. His work is characterized by a commitment to developing effective treatments that can significantly improve patient outcomes.

Collaborations

He collaborates with talented individuals such as Anna Nardi Ricart and Núria Reig Bolaño, contributing to a dynamic and innovative work environment. Their combined expertise enhances the research and development efforts at Som Innovation Biotech.

Conclusion

Oscar Huertas Gambín exemplifies the spirit of innovation in biotechnology through his patents and collaborative efforts. His contributions are paving the way for advancements in medical treatments, particularly for conditions like transthyretin-associated amyloidosis.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…